title: Radiochemotherapy for T1G3 bladder cancer.
authors.affiliation: Department of Radiotherapy, University of Halle, Germany. juergen.dunst@medizin.uni-halle.de
authors.forename: Jürgen
authors.initials: J
authors.lastname: Dunst
authors.forename: Claus
authors.initials: C
authors.lastname: Rödel
authors.forename: Andrea
authors.initials: A
authors.lastname: Diestelhorst
authors.forename: Hans
authors.initials: H
authors.lastname: Heynemann
authors.forename: Karl Michael
authors.initials: KM
authors.lastname: Schrott
authors.forename: Rolf
authors.initials: R
authors.lastname: Sauer
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001918:Brachytherapy; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D015653:Cystectomy / Q000379:methods; D018450:Disease Progression; D005500:Follow-Up Studies; D006801:Humans; D016685:Mitomycin / Q000627:therapeutic use*; D009361:Neoplasm Invasiveness; D009367:Neoplasm Staging; D016019:Survival Analysis; D016896:Treatment Outcome; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery
chemical_list: D000970:Antineoplastic Agents; D016685:Mitomycin